- Report
- October 2025
- 198 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 190 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 194 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 188 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 191 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 199 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 198 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 184 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- March 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,458GBP
- Report
- October 2025
- 392 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 384 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 485 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 140 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 402 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 375 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 492 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 378 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 407 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 392 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 286 Pages
Global
From €5189EUR$5,850USD£4,505GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more